|
TESK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.127800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.529400E-01 |
| Normal-vs-Stage2 |
4.866000E-02 |
| Normal-vs-Stage3 |
6.084300E-02 |
| Normal-vs-Stage4 |
2.551000E-01 |
| Stage1-vs-Stage2 |
1.692240E-01 |
| Stage1-vs-Stage3 |
3.108200E-01 |
| Stage1-vs-Stage4 |
6.889000E-01 |
| Stage2-vs-Stage3 |
4.753200E-01 |
| Stage2-vs-Stage4 |
4.349600E-01 |
| Stage3-vs-Stage4 |
7.734200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.089960E-01 |
| Normal-vs-AfricanAmerican |
6.312600E-01 |
| Normal-vs-Asian |
8.733600E-01 |
| Caucasian-vs-AfricanAmerican |
3.128400E-01 |
| Caucasian-vs-Asian |
3.177600E-01 |
| AfricanAmerican-vs-Asian |
5.922600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.499900E-02 |
| Normal-vs-Female |
1.309630E-01 |
| Male-vs-Female |
5.251000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.334400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.310850E-01 |
| Normal-vs-Age(61-80Yrs) |
2.760100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.857700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.851600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.214300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.183200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.236600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.301000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.416600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.809830E-02 |
| Classical-VS-Follicular |
3.16079999995722E-06 |
| Classical-VS-Other |
6.199600E-01 |
| Classical-VS-Normal |
8.561800E-01 |
| Tall-VS-Follicular |
2.145000E-01 |
| Tall-VS-Other |
9.895600E-02 |
| Tall-VS-Normal |
2.682400E-02 |
| Follicular-VS-Other |
5.007500E-02 |
| Follicular-VS-Normal |
1.188170E-04 |
| Other-VS-Normal |
5.816000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.022110E-02 |
| Normal-vs-N1 |
1.340390E-02 |
| N0-vs-N1 |
4.718400E-01 |
|
|
